Library / Laws / 119th Congress / House Bills / H.R. 7953
H.R. 7953
To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2026-03-17 | 10.6K | ⠃⠗⠋ |